Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
Kidney International|December 21, 2012
Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal diseaseWen Tang, Stephen P McDonald, Carmel M Hawley, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 19, 2012
Association between initial and pretransplant dialysis modality and graft and patient outcomes in live- and deceased-donor renal transplant recipientsWai H Lim, Philip Clayton, Germaine Wong, et al.
Lab on a Chip|February 10, 2022
Vasculature-on-a-chip platform with innate immunity enables identification of angiopoietin-1 derived peptide as a therapeutic for SARS-CoV-2 induced inflammationRick Xing Ze Lu, Benjamin Fook Lun Lai, Naimeh Rafatian, et al.
Nephrology (Carlton, Vic.)|May 15, 2007
Mineral metabolism, bone histomorphometry and vascular calcification in alternate night nocturnal haemodialysisCarolyn L Van Eps, Janine K Jeffries, John A Anderson, et al.
BMC Nephrology|July 29, 2009
Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial)Katherine A Barraclough, Euan Noble, Diana Leary, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 25, 2006
A randomized controlled trial of coiled versus straight swan-neck Tenckhoff catheters in peritoneal dialysis patientsDavid W Johnson, Jennifer Wong, Kathryn J Wiggins, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 21, 2005
Randomized trial of FX high flux vs standard high flux dialysis for homocysteine clearanceDavid W Mudge, Robyn Rogers, Peter Hollett, et al.
BMC Nephrology|October 4, 2011
Cardiac and vascular structure and function parameters do not improve with alternate nightly home hemodialysis: an interventional cohort studyCarolyn L van Eps, Leanne Jeffriess, Brian Haluska, et al.
BMC Nephrology|December 5, 2012
End-stage kidney disease due to haemolytic uraemic syndrome--outcomes in 241 consecutive ANZDATA registry casesWen Tang, Janaki Mohandas, Stephen P McDonald, et al.
BMC Nephrology|August 21, 2009
Rationale and design of the HEALTHY-CATH trial: a randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patientsJennifer K Broom, Stacey O'Shea, Sridevi Govindarajulu, et al.
Pageof 11